Good news can take many forms: a species-recovery milestone, a long-term education trend, trial results that merit further review, or more treatment capacity during a crisis. Here are four September stories, with the progress and the remaining challenges kept in view.
🦜
Species recovery
Kākāpō population reaches a recovery-era high of 325
On 1 September, 90 chicks from the 2026 breeding season were added to New Zealand’s official count after reaching the 150-day independence threshold. The critically endangered kākāpō population now stands at 325, a recovery-era high. This is a meaningful population milestone, while the species remains critically endangered.
Read the Department of Conservation update →
📚
Education access
More students are completing school than in 2000, UNESCO reports
UNESCO’s 2026 Global Education Monitoring report says there are 327 million more students enrolled in primary and secondary education than in 2000, and completion rose across levels between 2000 and 2024. The report also records a major unfinished challenge: 273 million children and young people remain out of school, with that number rising for seven consecutive years. The trend is progress, not a solved access gap.
Explore UNESCO’s findings →
🫁
Medical research
Two Phase III trials report fewer COPD exacerbations with tozorakimab
In the OBERON and TITANIA Phase III trials, involving 2,306 participants, AstraZeneca reported reductions in moderate-to-severe COPD exacerbations versus placebo. The results appeared in The New England Journal of Medicine. Tozorakimab remains investigational and is not approved; the trial results do not establish an individual outcome or guarantee future availability.
Read the trial update →
🩺
Humanitarian healthcare
MSF opens new Ebola treatment capacity in the DRC
MSF reported opening a 22-bed Ebola treatment centre in Kisangani earlier in September and a 50-bed centre in Nia Nia during the week of 23 September. The organization says more patients are reaching care alive and earlier. The outbreak remains serious, and added treatment capacity is an important response rather than a resolution.
Read MSF’s response update →
Good news grows through care.
Leaves of Dawn supports causes connected to forest restoration, cancer research, children and communities, and humanitarian healthcare. The developments featured here are independent stories; they were not caused or funded by our brand.
Continue Making a Difference 🌱
